Product Information
LAMIVUDINE HBV 100 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $8.1597 per EA under NDC 31722075260. Its NADAC has been published 517 times since Jun 4, 2014.
Strength
100 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722075260
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA203260On Market Since
1/2/2014
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE HBV 100 MG TABLET has been published 517 times since Jun 4, 2014, and over the history we have for it it has declined 23.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1597 per EA |
|---|---|
| All-time high | $11.2082 (Nov 12, 2014) |
| All-time low | $1.5548 (May 17, 2023) |
| Median price | $3.0295 |
| Average price | $4.7356 |
| Largest weekly change | +160.1% (Sep 18, 2024) |
| Weeks tracked | 517 |
| Tracking since | Jun 4, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE HBV 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE HBV 100 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $8.1597 per EA (NDC 31722075260), effective Nov 13, 2024.
How has the price of LAMIVUDINE HBV 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE HBV 100 MG TABLET has declined 23.9%. It has been tracked across 517 weekly CMS publications since Jun 4, 2014.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE HBV 100 MG TABLET?
Since Jun 4, 2014, the NADAC for LAMIVUDINE HBV 100 MG TABLET has ranged from a low of $1.5548 (May 17, 2023) to a high of $11.2082 (Nov 12, 2014), with a median of $3.0295 per EA.
Are there cheaper alternatives to LAMIVUDINE HBV 100 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LAMIVUDINE HBV 100 MG TABLET, but none are currently priced below it.
Who manufactures LAMIVUDINE HBV 100 MG TABLET?
LAMIVUDINE HBV 100 MG TABLET (NDC 31722075260) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification